LIVER

Intestinal absorption of the bile acid analogue ⁷⁵Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration

A Lanzini¹, M G De Tavonatti¹, B Panarotto², S Scalia³, A Mora¹, F Benini¹, O Baisini¹, F Lanzarotto¹

¹ Medicine 1, Spedali Civili and University of Brescia, Italy
² Nuclear Medicine, Spedali Civili and University of Brescia, Italy
³ Department of Pharmaceutical Sciences, University of Ferrara, Italy

Correspondence to:
Correspondence to:
Professor A Lanzini, Medicine 1, Spedali Civili, 25121 Brescia, Italy;
lanzini{at}med.unibs.it

Background: Whether ileal absorption of bile acid is up or downregulated in chronic cholestasis is still debated, and most evidence has come from animal studies.

Aims: To compare ileal bile acid absorption in patients with primary biliary cirrhosis (PBC) and in healthy control subjects, and to assess the effect of ursodeoxycholic acid (UDCA).

Patients: We studied 14 PBC patients before and during (n=11) UDCA administration, 14 healthy control subjects, and 14 Crohn’s disease patients (as disease controls).

Methods: We used cholescintigraphy to measure retention in the enterohepatic circulation over five successive days of the bile acid analogue ⁷⁵Se-homocholic acid-taurine (⁷⁵SeHCAT) as an index of ileal bile acid absorption. Results were expressed as ⁷⁵SeHCAT fractional turnover rate (FTR) and t12.

Results: ⁷⁵SeHCAT FTR was 0.19 (0.11)/day, 0.34 (0.11)/day (p<0.001), and 0.83 (0.32)/day in PBC patients, healthy controls (p<0.0001), and Crohn’s patients (p<0.001), respectively, which increased to 0.36 (0.16)/day in PBC patients during UDCA treatment (p<0.005). ⁷⁵SeHCAT t12 was 4.8 (2.1) days in PBC patients, 2.2 (0.5) days (p<0.001) in healthy controls, and 1.0 (0.5) days (p<0.001) in Crohn’s disease patients. ⁷⁵SeHCAT t12 decreased to 2.2 (0.93) days (p< 0.001) in PBC patients during UDCA treatment.

Conclusions: Our results support the concept that ileal bile acid absorption is upregulated in PBC patients, and that this effect may contribute towards damaging the cholestatic liver. This upregulation of bile acid absorption is abolished by UDCA.

Keywords: ⁷⁵Se-homocholic acid-taurine; primary biliary cirrhosis; bile acid; ursodeoxycholic acid; intestinal absorption

Abbreviations: PBC, primary biliary cirrhosis; ⁷⁵SeHCAT; ⁷⁵Se-homocholic acid-taurine; UDCA, ursodeoxycholic acid; FTR, fractional turnover rate

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry

A F Hofmann
Gut 2003 52: 1239-1241. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Dawson, P. A., Lan, T., Rao, A. (2009). Bile acid transporters. J. Lipid Res. 50: 2340-2357 [Abstract] [Full Text]  
• Lefebvre, P., Cariou, B., Lien, F., Kuipers, F., Staels, B. (2009). Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation. Physiol. Rev. 89: 147-191 [Abstract] [Full Text]  
• Hruz, P, Zimmermann, C, Gutmann, H, Degen, L, Beuers, U, Terracciano, L, Drewe, J, Beglinger, C (2006). Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. Gut 55: 395-402 [Abstract] [Full Text]  
• Hofmann, A F (2003). Inappropriate ileal conservation of bile acids in cholestatic liver disease: homeostasis gone awry. Gut 52: 1239-1241 [Full Text]